Piperacillin-tazobactam

Individualized Treatment Effects of Cefepime vs Piperacillin-Tazobactam in Adults Hospitalized with Acute Infection: A Review of Evidence and Clinical Implications

By MedXY 10/13/2026

This review synthesizes evidence on how individual patient characteristics modify the comparative effects of cefepime versus piperacillin-tazobactam on acute kidney injury and neurologic outcomes in adults hospitalized with acute infection.

Critical Care Infectious Diseases news

White Blood Cell Count as a Predictor of Antibiotic Efficacy in Sepsis: Insights from Comparative Studies of Cefepime and Piperacillin-Tazobactam

By MedXY 10/09/2026

White blood cell count modifies mortality outcomes in sepsis patients treated with cefepime versus piperacillin-tazobactam, suggesting its potential role in guiding antibiotic selection.

General Surgery Infectious Diseases news

Early Uptake of Broad-Spectrum Antibiotic Prophylaxis in Pancreatoduodenectomy: Translating Trial Evidence into Practice

By MedXY 08/21/2026

Following pivotal trial data demonstrating reduced infection and pancreatic fistula rates with piperacillin-tazobactam prophylaxis in pancreatoduodenectomy, adoption of broad-spectrum antibiotics increased significantly, particularly among patients with biliary stents, though racial disparities in use persisted.

Clinical Updates Infectious Diseases news Specialties

Is Piperacillin-Tazobactam Safe for Patients with Amoxicillin Allergy? Insights from a Recent Clinical Study

By MedXY 08/31/2025

A recent study shows that over 80% of patients allergic to amoxicillin tolerate piperacillin-tazobactam, though about 18% experience cross-reactivity, highlighting the need for careful allergy testing before use.